Picture of Genovis AB logo

GENO Genovis AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Annual cashflow statement for Genovis AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3.1424.58.2854.245.7
Non-Cash Items5.435.775.889.52-19.4
Other Non-Cash Items
Changes in Working Capital-4.8215.6-15.14.0110.8
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities3.7645.9-0.92867.837.1
Capital Expenditures-20.4-4.49-3.83-12.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items014.4
Other Investing Cash Flow
Cash from Investing Activities-20.4-4.49-3.83-12.814.4
Financing Cash Flow Items-5.36
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities45.8-4.23-3.73-4.51-5.36
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash29.137.2-8.4850.446.2